144 related articles for article (PubMed ID: 4614096)
1. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
Fischer PA
Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
[No Abstract] [Full Text] [Related]
2. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
[No Abstract] [Full Text] [Related]
3. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
4. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
Fischer PA; Schneider E; Jacobi P; Maxion H
Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
[No Abstract] [Full Text] [Related]
5. [Side-effects of L-dopa therapy].
Girke W; Xenakis Ch
Dtsch Med Wochenschr; 1975 Oct; 100(42):2165-9. PubMed ID: 1100342
[No Abstract] [Full Text] [Related]
6. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Gattringer B; Steinhäusl H
Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
[No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
[No Abstract] [Full Text] [Related]
8. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Guillard A
Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
[No Abstract] [Full Text] [Related]
9. [Modalities of treatment of Parkinsonian syndrome with L-dopa].
Yanniotis G; Eisenring JJ; Gauthier G; Tissot R; de Ajuriaguerra J
Int J Neurol; 1972; 9(1):23-32. PubMed ID: 5086635
[No Abstract] [Full Text] [Related]
10. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
11. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.
Muenter MD; Tyce GM
Mayo Clin Proc; 1971 Apr; 46(4):231-9. PubMed ID: 5573818
[No Abstract] [Full Text] [Related]
12. [Review of problems in the treatment of the parkinsonian syndrome with L-dopa].
Piccirilli M; Quartesan R
Clin Ter; 1976 Mar; 76(5):467-77. PubMed ID: 991553
[No Abstract] [Full Text] [Related]
13. [Aspects of hypersexuality observed in parkinsonian patients treated by L-dopa].
Ballivet J; Marin A; Gisselmann A
Ann Med Psychol (Paris); 1973 Nov; 2(4):515-22. PubMed ID: 4799646
[No Abstract] [Full Text] [Related]
14. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; de Ajuriaguerra J
Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
[No Abstract] [Full Text] [Related]
15. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
16. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
Jenkins AC; Schwieger AC
Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186
[No Abstract] [Full Text] [Related]
17. [Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
Tissot R; Gaillard JM; Guggisberg M; Gauthier G; De Ajuriaguerra J
Neurol Neurocir Psiquiatr; 1969; 10(1):1-25. PubMed ID: 5406970
[No Abstract] [Full Text] [Related]
18. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
[No Abstract] [Full Text] [Related]
19. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
[No Abstract] [Full Text] [Related]
20. [Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].
Völler GW; Muschard F
Med Welt; 1973 Apr; 24(17):705-7. PubMed ID: 4750934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
